Panzram, B., & Schiltenwolf, M. (2014). Pain therapy with high risk: One-sided presentation of the results from the latest phase III study on tanezumab in osteoarthritis pain. Pain, 155(11), . https://doi.org/10.1016/j.pain.2014.08.006
Chicago-Zitierstil (17. Ausg.)Panzram, Benjamin, und Marcus Schiltenwolf. "Pain Therapy with High Risk: One-sided Presentation of the Results from the Latest Phase III Study on Tanezumab in Osteoarthritis Pain." Pain 155, no. 11 (2014). https://doi.org/10.1016/j.pain.2014.08.006.
MLA-Zitierstil (9. Ausg.)Panzram, Benjamin, und Marcus Schiltenwolf. "Pain Therapy with High Risk: One-sided Presentation of the Results from the Latest Phase III Study on Tanezumab in Osteoarthritis Pain." Pain, vol. 155, no. 11, 2014, https://doi.org/10.1016/j.pain.2014.08.006.